<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02584088</url>
  </required_header>
  <id_info>
    <org_study_id>15-029</org_study_id>
    <nct_id>NCT02584088</nct_id>
  </id_info>
  <brief_title>Ultrasound Appearance of the Endometrium Post Radio-Frequency Ablation</brief_title>
  <official_title>Ultrasound Appearance of the Endometrium Post Radio-Frequency Ablation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>TriHealth Inc.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>TriHealth Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      -  The study primarily aims to evaluate the post ablative endometrium and uterus using
           transvaginal ultrasound to provide descriptive information as to what may be expected in
           the 12 months after a NovaSure ablation. Investigators believe this knowledge will help
           them to determine when to proceed with further evaluation postoperatively or when to
           counsel patients on expectant management based on ultrasonographic findings.

        -  Secondary aims include correlation of ultrasonographic findings to demographic patient
           data.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Heavy and irregular menses affects 9-14% of gynecologic patients. Surgical can be employed
      intervention is sought when medical management fails. Endometrial ablation or desiccation of
      the endometrium using minimally invasive instruments has been utilized in this scenario. The
      current mainstay intervention is non-resectoscopic radio frequency ablation. These procedures
      have high satisfaction rates (81 to 93%) similar to hysterectomy and leave up to 47% of
      patients amenorrheic. Post operative complications, both short and long term, and failure
      rates have been well studied. A limited number of studies have been performed to assess the
      histologic state of the post ablative endometrium and fewer assessing the radiographic
      appearance of the endometrium. Therefore, this current study aims to describe the
      ultrasonographic appearance of the post ablative endometrium and uterus.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 11, 2016</start_date>
  <completion_date type="Anticipated">May 2018</completion_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Endometrial thickness (measured using a scale)</measure>
    <time_frame>2 months</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Menorrhagia</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Ultrasound</intervention_name>
    <description>The appearance of the post ablative endometrium on transvaginal ultrasound at 2, 6, and 12 months.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who are candidates for NovaSure ablation for treatment of menorrhagia.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  women of premenopausal age

          -  18 years and older

          -  intended ablative management of menorrhagia

        Exclusion Criteria:

          -  uterine cavity anatomic abnormality

          -  previous uterine ablation procedure

          -  previous cervical procedure

          -  presence of submucosal fibroids

          -  tissue diagnosis of endometrial hyperplasia/endometrial carcinoma

          -  pregnancy and delivery less than 1 year before ablation.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Catrina Crisp, MD, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>TriHealth Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ganga Devaiah, MS</last_name>
    <phone>513-862-2341</phone>
    <email>ganga_devaiah@trihealth.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Pam Plummer, MSN, RN</last_name>
    <phone>513-852-6918</phone>
    <email>pam_plummer@trihealth.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Good Samaritan Hospital</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45220</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Bethesda North Hospital</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45242</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>El-Nashar SA, Hopkins MR, Creedon DJ, St Sauver JL, Weaver AL, McGree ME, Cliby WA, Famuyide AO. Prediction of treatment outcomes after global endometrial ablation. Obstet Gynecol. 2009 Jan;113(1):97-106. doi: 10.1097/AOG.0b013e31818f5a8d. Erratum in: Obstet Gynecol. 2010 Mar;115(3):663.</citation>
    <PMID>19104365</PMID>
  </reference>
  <reference>
    <citation>Dickersin K, Munro MG, Clark M, Langenberg P, Scherer R, Frick K, Zhu Q, Hallock L, Nichols J, Yalcinkaya TM; Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding (STOP-DUB) Research Group. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding: a randomized controlled trial. Obstet Gynecol. 2007 Dec;110(6):1279-89. Erratum in: Obstet Gynecol. 2008 Aug;112(2 Pt 1):381.</citation>
    <PMID>18055721</PMID>
  </reference>
  <reference>
    <citation>Alhilli MM, Wall DJ, Brown DL, Weaver AL, Hopkins MR, Famuyide AO. Uterine ultrasound findings after radiofrequency endometrial ablation: correlation with symptoms. Ultrasound Q. 2012 Dec;28(4):261-8. doi: 10.1097/RUQ.0b013e318276653b.</citation>
    <PMID>23149510</PMID>
  </reference>
  <reference>
    <citation>Ahonkallio SJ, Liakka AK, Martikainen HK, Santala MJ. Feasibility of endometrial assessment after thermal ablation. Eur J Obstet Gynecol Reprod Biol. 2009 Nov;147(1):69-71. doi: 10.1016/j.ejogrb.2009.06.014. Epub 2009 Jul 16.</citation>
    <PMID>19615812</PMID>
  </reference>
  <reference>
    <citation>Penninx JP, Herman MC, Mol BW, Bongers MY. Five-year follow-up after comparing bipolar endometrial ablation with hydrothermablation for menorrhagia. Obstet Gynecol. 2011 Dec;118(6):1287-92. doi: 10.1097/AOG.0b013e318236f7ed.</citation>
    <PMID>22105257</PMID>
  </reference>
  <reference>
    <citation>Luo X, Lim CE, Li L, Wong WS. Hysteroscopic appearance of endometrial cavity after microwave endometrial ablation. J Minim Invasive Gynecol. 2010 Jan-Feb;17(1):30-6. doi: 10.1016/j.jmig.2009.09.012.</citation>
    <PMID>20129329</PMID>
  </reference>
  <reference>
    <citation>Onoglu A, Taskin O, Inal M, Sadik S, Simsek M, Akar M, Kursun S, Mendilcioglu I, Postaci H, Ispahi C. Comparison of the long-term histopathologic and morphologic changes after endometrial rollerball ablation and resection: a prospective randomized trial. J Minim Invasive Gynecol. 2007 Jan-Feb;14(1):39-42.</citation>
    <PMID>17218227</PMID>
  </reference>
  <reference>
    <citation>Taskin O, Onoglu A, Inal M, Turan E, Sadik S, Vardar E, Postaci H, Wheeler JM. Long-term histopathologic and morphologic changes after thermal endometrial ablation. J Am Assoc Gynecol Laparosc. 2002 May;9(2):186-90.</citation>
    <PMID>11960046</PMID>
  </reference>
  <reference>
    <citation>Leung PL, Tam WH, Yuen PM. Hysteroscopic appearance of the endometrial cavity following thermal balloon endometrial ablation. Fertil Steril. 2003 May;79(5):1226-8.</citation>
    <PMID>12738523</PMID>
  </reference>
  <reference>
    <citation>Colgan TJ, Shah R, Leyland N. Post-hysteroscopic ablation reaction: a histopathologic study of the effects of electrosurgical ablation. Int J Gynecol Pathol. 1999 Oct;18(4):325-31.</citation>
    <PMID>10542940</PMID>
  </reference>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 20, 2015</study_first_submitted>
  <study_first_submitted_qc>October 21, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 22, 2015</study_first_posted>
  <last_update_submitted>July 26, 2017</last_update_submitted>
  <last_update_submitted_qc>July 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>NovaSure</keyword>
  <keyword>Ablation</keyword>
  <keyword>Menorrhagia</keyword>
  <keyword>Endometrium</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Menorrhagia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

